Tinubu approves 25 new cancer treatment machines, FG begins wider cancer-care expansion

President Bola Ahmed Tinubu has approved the procurement of 25 additional linear accelerators between 2027 and 2029 as part of the Federal Government’s efforts to expand cancer treatment capacity and strengthen cancer control in Nigeria.

The Minister of State for Health and Social Welfare, Dr Iziaq Salako, disclosed this on Tuesday in Abuja during a meeting of the National Cancer Control Plan (NCCP) Technical Working Group and Global Advisory Council.

Salako said the approval was part of a three-year plan to increase access to radiotherapy and other specialised cancer services across the country.

“Recently, President Bola Tinubu approved that between 2027 and 2029, the country should procure an additional 25 linear accelerators. We are executing a three-year plan to achieve this,” the minister said.

Linear accelerators, commonly known as LINACs, are machines used in radiotherapy to deliver high-energy radiation to cancer cells while limiting damage to surrounding healthy tissue. Their availability is critical to the treatment of many cancer patients requiring radiation therapy.

The planned procurement comes under the Federal Government’s National Cancer Control Plan 2026–2030, which seeks to reduce cancer incidence, illness and deaths while improving access to prevention, early detection, diagnosis, treatment and supportive care.

Salako said Nigeria continued to face a significant cancer burden, with many patients presenting at health facilities when their diseases had already reached advanced stages.

He identified inadequate infrastructure, shortages of skilled healthcare workers and limited funding among the challenges affecting cancer treatment and care in the country.

READ ALSO:

• Soso Soberekon Offers Peter Okoye N500m to Fight Twin Brother Paul in Boxing Match
• University Student Stabbed to Death Over Alleged £3,000 Debt, Fake Rolex
• ‘Don’t Let My Sick Daughter Die in Nigeria’ — Nigerian US Army Woman Begs Trump

The minister said the government was therefore pursuing a comprehensive cancer-control strategy that places equal emphasis on prevention, early detection, treatment, research, workforce development and partnerships.

Prevention, he said, remains a major priority of the administration.

Salako noted that President Tinubu had approved the inclusion of Human Papillomavirus (HPV) vaccination in Nigeria’s routine immunisation programme.

“The President particularly continues to emphasise prioritising prevention. That is why one of the very first things he did was to approve that routinely, HPV vaccination should be part of our immunisation schedule,” he said.

HPV vaccination is an important public-health intervention because persistent infection with certain HPV types can cause cervical cancer and other cancers.

Salako added that the Federal Government was also working to strengthen hepatitis vaccination, expand cervical cancer screening and integrate screening services into primary healthcare facilities across the country.

“Prevention is better and cheaper than cure,” he said.

Beyond prevention, the government is also expanding specialised treatment infrastructure.

Salako disclosed that construction of six Cancer Centres of Excellence had commenced, with three already completed and work progressing on the remaining centres.

The centres are expected to improve access to specialised oncology services across Nigeria’s six geopolitical zones and reduce the pressure on existing cancer-treatment facilities.

The minister also inaugurated the Blood Cancer Consortium following the donation of equipment and other resources aimed at strengthening pathology laboratories and improving the diagnosis and management of blood cancers.

The President of the Nigerian Cancer Society, Prof. Abidemi Omonisi, commended the Federal Government for adopting a more coordinated approach to tackling cancer.

READ ALSO:

• Death Toll Rises to 132 as 7.4-Magnitude Earthquake Devastates Western Colombia
• How Enugu Abduction Led to Recovery of 4 AK-47 Rifles, 133 Ammunition – Army
• ‘I Acted Out of Patriotism’ — Army Colonel Ma’aji Breaks Silence, Explains Why He Plotted Coup Against Tinubu

Omonisi identified fragmented interventions among government agencies, development partners, researchers and other stakeholders as one of the challenges that had affected previous cancer-control efforts.

He said the NCCP Technical Working Group was helping to address the problem by bringing together government institutions, researchers, clinicians, development partners, cancer organisations, patients and other stakeholders under a common national framework.

According to him, stronger international partnerships and greater engagement with Nigerians in the diaspora could improve cancer research, technology transfer, workforce development and access to advanced cancer-care services.

Earlier, the Chair of the NCCP Technical Working Group, Prof. Folakemi Odedina, said the group had moved from planning to implementation.

She said the initiative had united government institutions, academics, patients, advocates, survivors, industry players and international partners around a common national cancer-control agenda.

Odedina said work was progressing across several areas, including cancer prevention, early detection, treatment, survivorship, palliative care, research, clinical trials, workforce development and digital health.

She added that the Global Advisory Council was providing expertise in cancer prevention and treatment, genomics, implementation science, workforce development, data management and artificial intelligence.

Odedina said efforts were also underway to strengthen Nigeria’s oncology clinical trials ecosystem and improve patients’ access to innovative treatment options.

“We intend to produce trained people, stronger institutions in Nigeria, better research, expanded clinical trials, improved technologies, greater access to care, and ultimately better outcomes for Nigerian cancer patients,” she said.

She, however, stressed that expanding medical treatment alone would not guarantee better outcomes if patients could not afford other costs associated with cancer care.

According to her, patients may also require support for transportation, nutrition and accommodation during treatment, particularly when specialised services are unavailable close to their communities.

Also speaking, Prof. Taofeek Owonikoko, Global Advisory Council Director at the University of Maryland Greenebaum Cancer Centre, said the partnership would strengthen coordination between Nigerian institutions and international cancer organisations.

He said the framework would help ensure that international interventions were aligned with Nigeria’s national priorities rather than operating independently.

Owonikoko described the ambition of achieving a cancer-free Nigeria by 2030 as a long-term goal that would require sustained investment in healthcare systems, research, infrastructure and treatment strategies.

“I’m very convinced that the 2030 cancer-free Nigeria is not going to be a slogan.

“While we may not make Nigeria cancer-free in 2030, I think we would have created the tools, the platform and the strategies that will ensure that we eventually become cancer-free,” he said.

Dr Lewis Roberts of Mayo Clinic Comprehensive Cancer Centre called for increased attention to liver, pancreatic and biliary tract cancers across Africa.

“Liver cancer is one of the major causes of cancer deaths in Africa. Across the continent, it’s the number three cause of death from cancer,” Roberts said.

He advocated stronger screening programmes, improved identification and treatment of viral hepatitis cases and wider vaccination coverage to reduce the incidence of liver cancer.

The Federal Government’s broader cancer strategy also places emphasis on research, cancer surveillance, data collection, digital health and the development of a specialised workforce capable of providing modern oncology services.

The NCCP 2026–2030 is designed to bring together federal and state governments, healthcare professionals, researchers, patients, survivors, civil society organisations, development partners and international institutions in a coordinated national response to cancer.

The government’s planned procurement of 25 additional linear accelerators, construction of six Cancer Centres of Excellence, expansion of screening programmes and strengthening of pathology and research facilities are therefore part of a wider attempt to improve Nigeria’s cancer-care system.

However, stakeholders say sustained funding, reliable infrastructure, adequate staffing and affordable access to treatment will remain essential if the new investments are to translate into better outcomes for people living with cancer.

The meeting reviewed progress under the National Cancer Control Plan and examined further strategies for strengthening coordinated action on cancer prevention, early detection, diagnosis, treatment, research and survivorship care across Nigeria.

Tinubu approves 25 new cancer treatment machines, FG begins wider cancer-care expansion